Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.

Part D is the section of Medicare that covers most pharmaceutical products. Notably, the out-of-pocket cap which was $8,000 per year will decrease to $2,000.

With the start of 2025, Medicare beneficiaries will benefit from a new $2,000 cap on out-of-pocket prescription drug costs, a significant change aimed at easing

A provision of the Inflation Reduction Act will cap out-of-pocket costs for prescription drugs at $2,000 per year for people with Medicare Part D.

Medicare will begin capping prescription drug costs at $2,000 annually, a move expected to save millions of Americans money on medications. (Scripps News)